Sophie Testa to Hemorrhage
This is a "connection" page, showing publications Sophie Testa has written about Hemorrhage.
Connection Strength
0.769
-
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
Score: 0.300
-
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. J Thromb Haemost. 2020 06; 18(6):1320-1323.
Score: 0.086
-
The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study. Intern Emerg Med. 2019 11; 14(8):1307-1315.
Score: 0.081
-
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study. Int J Cardiol. 2018 Sep 15; 267:68-73.
Score: 0.077
-
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma. Cardiovasc Ther. 2018 Feb; 36(1).
Score: 0.072
-
Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation. Am J Cardiol. 2017 Apr 01; 119(7):1012-1016.
Score: 0.068
-
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine (Baltimore). 2016 Dec; 95(52):e5451.
Score: 0.068
-
Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Intern Emerg Med. 2017 Dec; 12(8):1109-1119.
Score: 0.017